Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited ( (AU:NEU) ) just unveiled an announcement.
Neuren Pharmaceuticals Limited has announced its Annual Shareholders’ Meeting scheduled for 27 May 2025, to be held both physically in Melbourne and online. This hybrid meeting format allows shareholders to participate, vote, and ask questions either in person or via an online platform, reflecting the company’s commitment to accessibility and shareholder engagement.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited is a company incorporated in New Zealand, operating in the pharmaceutical industry. The company focuses on developing therapies for neurodevelopmental disorders and other related conditions, aiming to address unmet medical needs in this specialized market.
YTD Price Performance: -9.02%
Average Trading Volume: 1,133
Technical Sentiment Signal: Buy
Current Market Cap: $850.6M
For an in-depth examination of NEU stock, go to TipRanks’ Stock Analysis page.